Department of Ophthalmology, Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California 94304, United States.
Department of Materials Science and Engineering, Stanford University, Stanford, California 94305, United States.
ACS Nano. 2024 Aug 20;18(33):21925-21938. doi: 10.1021/acsnano.4c02345. Epub 2024 Aug 6.
Corneal defects can lead to stromal scarring and vision loss, which is currently only treatable with a cadaveric corneal transplant. Although -forming hydrogels have been shown to foster regeneration of the cornea in the setting of stromal defects, the cross-linking, biomechanical, and compositional parameters that optimize healing have not yet been established. This, Corneal defects are also almost universally inflamed, and their rapid closure without fibrosis are critical to preserving vision. Here, an forming, bioorthogonally cross-linked, nanocluster (NC)-reinforced collagen and hyaluronic acid hydrogel (NCColHA hydrogel) with enhanced structural integrity and both pro-regenerative and anti-inflammatory effects was developed and tested within a corneal defect model . The NCs serve as bioorthogonal nanocross-linkers, providing higher cross-linking density than polymer-based alternatives. The NCs also serve as delivery vehicles for prednisolone (PRD) and the hepatocyte growth factor (HGF). NCColHA hydrogels rapidly gel within a few minutes upon administration and exhibit robust rheological properties, excellent transparency, and negligible swelling/deswelling behavior. The hydrogel's biocompatibility and capacity to support cell growth were assessed using primary human corneal epithelial cells. Re-epithelialization on the NCColHA hydrogel was clearly observed in rabbit eyes, both and , with expression of normal epithelial biomarkers, including CD44, CK12, CK14, α-SMA, Tuj-1, and ZO-1, and stratified, multilayered morphology. The applied hydrogel maintained its structural integrity for at least 14 days and remodeled into a transparent stroma by 56 days.
角膜缺陷可导致基质瘢痕和视力丧失,目前只能通过尸体角膜移植进行治疗。虽然 -形成水凝胶已被证明可在基质缺陷的情况下促进角膜再生,但尚未确定优化愈合的交联、生物力学和组成参数。此外,角膜缺陷也几乎普遍存在炎症,其快速闭合而无纤维化对于保持视力至关重要。在这里,我们开发并测试了一种具有增强结构完整性和促再生及抗炎作用的 -形成、生物正交交联、纳米团簇(NC)增强的胶原和透明质酸水凝胶(NCColHA 水凝胶),该水凝胶可用于治疗角膜缺陷模型。NC 用作生物正交纳米交联剂,提供比基于聚合物的替代物更高的交联密度。NC 还可用作泼尼松龙(PRD)和肝细胞生长因子(HGF)的递送载体。NCColHA 水凝胶在给药后几分钟内迅速凝胶,表现出强劲的流变特性、极好的透明度和可忽略不计的溶胀/去溶胀行为。该水凝胶的生物相容性和支持细胞生长的能力通过原代人角膜上皮细胞进行了评估。在兔眼的和,NCColHA 水凝胶上明显观察到再上皮化,表达正常的上皮生物标志物,包括 CD44、CK12、CK14、α-SMA、Tuj-1 和 ZO-1,以及分层、多层形态。应用水凝胶至少在 14 天内保持其结构完整性,在 56 天内重塑为透明的基质。